Joshua Klopper - Concepedia

Author

Joshua Klopper

University of Colorado Denver ORCID

Also Known As

J P Klopper, J. Klopper, J. P. Klopper, Joshua Klopper, Joshua P Klopper, Joshua P. Klopper

Publications

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver University of Colorado Cancer Center Mayo Clinic in Florida Memorial Sloan Kettering Cancer Center University of Colorado Health

About

Joshua Klopper is an author at University of Colorado Denver specializing in medicine, oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	463
2	Cell Biology	4	4	233
3	Pharmacology	3	3	218
4	Biostatistics	1	1	215
5	Pathology	1	1	215

Joshua Klopper

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules Yuri E. Nikiforov, David L. Steward, Toni M. Robinson-Smith, The Journal of Clinical Endocrinology & Metabolism	2009	700
Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification Rebecca E. Schweppe, Joshua Klopper, Christopher Korch, The Journal of Clinical Endocrinology & Metabolism	2008	563
Multicenter Clinical Experience With the Afirma Gene Expression Classifier Erik K. Alexander, Melanie Schorr, Joshua Klopper, The Journal of Clinical Endocrinology & Metabolism Thyroid Nodule CytologyOncologyAfirma GecMulticenter Clinical ExperienceMedicine	2013	215
Tumor-Associated Lymphocytes and Increased FoxP3+ Regulatory T Cell Frequency Correlate with More Aggressive Papillary Thyroid Cancer Jena D. French, Zachary Weber, Deborah Fretwell, The Journal of Clinical Endocrinology & Metabolism	2010	191
The Impact of Benign Gene Expression Classifier Test Results on the Endocrinologist–Patient Decision to Operate on Patients with Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytopathology Daniel S. Duick, Joshua Klopper, James Diggans, Thyroid	2012	148
Programmed Death-1+ T Cells and Regulatory T Cells Are Enriched in Tumor-Involved Lymph Nodes and Associated with Aggressive Features in Papillary Thyroid Cancer Jena D. French, Gregory Kotnis, Sherif Said, The Journal of Clinical Endocrinology & Metabolism	2012	135
Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1 John A. Copland, Laura A. Marlow, Shinichi Kurakata, Oncogene OncologyMedicineCancer Cell BiologyAnti-cancer AgentCancer Treatment	2005	132
Retinoic Acid and Retinoid X Receptors Are Differentially Expressed in Thyroid Cancer and Thyroid Carcinoma Cell Lines and Predict Response to Treatment with Retinoids Bryan R. Haugen, Lori Lee Larson, Umarani Pugazhenthi, The Journal of Clinical Endocrinology & Metabolism	2004	116
Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial Robert C. Smallridge, John A. Copland, Marcia S. Brose, The Journal of Clinical Endocrinology & Metabolism	2013	112
Management of recurrent and persistent metastatic lymph nodes in well‐differentiated thyroid cancer: A multifactorial decision‐making guide for the thyroid cancer care collaborative Mark L. Urken, Mira Milas, Gregory W. Randolph, Head & Neck	2014	86

Page 1